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MEASUREMENT OF BONE FORMATION IN A 57 YEAR 
OLD MAN BY MEANS OF TETRACYCLINES* 
H. M . FROST, A. R. VILLANUEVA AND H . ROTH 
Untfl Hiroshima and Nagasaki assumed international importance, the rates and 
modes of bone turnover in man were primarily academic matters. The advent of atomic 
weapons, weapons testing, the risks attendant to their manufacture and increasing 
clinical use of radioisotopes made the physiology of bone turnover in man a practical 
problem. Research intended to illuminate mechanisms, rates and quantities associated 
with turnover of bone and bone-seeking substances has been hampered by limitations 
imposed in using man as a laboratory animal. The immediate and latent risks attend-
ing administration of radioisotopes limit the applicability of existing radioanalytical 
techniques to bone at the light microscopic level. The large and detafled body of 
knowledge gained from animal work needs qualitative and quantitative corroboration 
in man before it can be applied to him. As a result of this state of affairs and others 
undiscussed, we do not have actual measurements of bone-forming activity in man 
at present. Such measurements are increasingly necessary for work in the fields of 
radiobiology, osteoporosis of afl types, osteomalacia, growth and fracture healing. 
This paper ampflfles basic work of Mflch, Rail and Tobie."." They noted the 
fixation of tetracycline antibiotics in mineralizing parts of the skeleton (tetracycline bone 
labelling) and subsequently detected the drugs by fluorescence in undecalcified bone 
sections. Our contributions to their work include amplification of the optical behavior 
of achromycin," an economical method of observing tetracycline fluorescence in bone" 
and iflustration with a single human case of the kind of information which tetracycline 
labelling may yield. 
We feel the chief value of this paper is that it presents simple, reliable, effective 
and precise techniques for measuring bone formation in man in vivo. With these 
techniques, it should be possible to determine with considerable precision the factors 
affecting human osteoblastic activity. 
Tetracycline bone labelling has the advantages of little immediate and no known 
latent risk. Numerous opportunities in large medical centers occur to obtain human 
tetracycline labelled bone from both sexes, all ages and diverse disease states. Use 
of tetracyclines in human experimentation should be safe. 
By virtue of their permanent fixation in mineralizing, new skeletal tissue the 
tetracyclines label bone forming activity current during the period of drug dosage.'^'"'"." 
Suitable preparation and examination of bones from patients who received tetracyclines 
at known times and for known duration permits us to measure their bone turnover 
more than 6 years after tetracycline administration. It is an eerie feeling to realize 
that one can measure precisely the osteoblastic activity going on in a bone 6 or more 
years before the patient died!" 
Using tetracycline labelled bone from 43 patients, and with the aid of methods 
largely developed in the Henry Ford Hospital Orthopaedic Research Laboratory, we 
*Supported by Grant No. 293, Henry Ford Hospital. 
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have been able to measure in man, in vivo: the biological half life of Haversian bone; 
the biological half life of entire bones; rates, quantities and variations in remodelling 
activity in different bones; osteoblastic activity; and the time required to form 
Haversian systems. 
In this paper the methods used for such measurements are outlined through 
the device of analyzing one human case. Some of the kinds of information that can 
be wrung from tetracycline labelling are presented for this case. Presentation of de-
tailed measurements of large numbers of human cases, and the effects of disease on 
bone turnover, will be presented in separate publications. 
MATERIALS 
The materials studied herein are the middle thirds of the femur, tibia, fibula and 
entire second metatarsal of the amputated left lower extremity. Corroboratory material 
for some of the minor points presented in the following paragraphs are sections made 
as recommended from more than 40 other patients who received tetracyclines before 
death or surgery." Clinical details of the case are presented in Appendix ( A ) . 
METHODS 
Four or more complete cross sections of the listed bones were made, stained 
and mounted by Frost's techniques.'.' 
Fluorescence: As noted by Mflch and coworkers"." refrigeration does not affect 
tetracycline fluorescence in bone. Material stored in bulk 8 months is unaffected. 
Thin sections kept in ethanol, however, gradually lose their fluorescence over many 
weeks. Permanent mounts made as recommended have not faded perceptibly in 3 years. 
Tetracycline fixed in bone in vivo does fade perceptibly after 6 years of life." 
The microfluorescence equipment used by Milch and coworkers is excellent. 
Fluorescence can also be energized by a 430 mu band in the visual spectrum. A set-up 
for this method is Wratten 47 and 47B filters in series in the light source and Wratten 
8 and 9 filters in series over the eyepiece. The light source should be a high intensity 
tungsten source such as a 300 watt 35 mm slide projector. Kohler illumination is 
superior to others with this arrangement.' Tetracyclines fixed in tissue fluoresce strongly 
with this arrangement. Their color is white to gold depending on drug concentration 
and section thickness. Background is a faint green or magenta. Fluorescence may be 
proved by passing the Wratten 8 filter under the condenser, whereupon fluorescence 
abruptly ceases. The condenser should be racked close to the slide and the aperture 
stop be wide open. For further details consult reference (13). See Figure 2. 
Yellow color in bright field Microscopy: Achromycin" in achromycin-Iabelled 
sections prepared as recommended'.' develops a lemon yellow color within one to 14 
days of mounting (in Harleco synthetic resin-xylene)." Failure to stain and mount 
as recommended usually prevents this color from appearing. The color does not 
develop in bulk material. Once developed it appears to be permanent as long as 
(a) All of the currently available tetracycline antibiotics, singly or in combination, are nearly equally 
suitable for work of the type described in this paper. 
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the mount is preserved. The visible yellow areas correspond precisely to the fluorescent 
areas. Very thin planes of achromycin labelling, or zones labefled during time of low 
dosage, may not develop detectable yellow in bright field but will fluoresce. 
Appearance of tetracycline labelled bone: Labelled bone appears as yellow-stained 
bands, the bands being paraflel to and in the substance of lameflae. Bands do not 
cross lamellae or cement lines. The drug deposits in mineralizing bone and cartilage 
and appears fixed there by subsequent mineralization. No diffusion out of labelled 
volumes of bone has been seen in mounts 3 years old or in bulk material 8 months 
old. The labelled band-width is a direct function of duration of dosage and rate 
of mineralization of osteoid while intensity of fluorescence and visual yellow is a 
function of dosage per day. When life continues after cessation of dosage the labelled 
bone and calcified cartilage become buried by unlabefled bone and calcified cartilage 
unless appositional growth ceased during drug administration. During the period of 
tetracycline administration most tissues are stained by the drug. Within 48 hours of 
drug cessation "adventitious" tetracycline has disappeared from bone, leaving only 
the labelled bone and calcified cartilage behind as a tell-tale. This and other observa-
tions suggest to us that tetracycline staining of bone is ordinarily a readily reversible 
phenomenon due at least in part to the ability of tetracycline antibiotics to complex 
with calcium ions. For further details consult references (12, 26, 27). 
Permanent staining of Haversian canals, osteocyte lacunae in Haversian systems 
and calcified cartilage (which were mature during the period of drug administration) 
has not been seen."."." 
Observation of the visual yellow in tetracycline labelled undecalcified sections 
is aided by use of light corrected to 5000°K, apochromats and fully illuminated ob-
jectives.'." 
Photomicrography: The visual yeflow in brightfield is due to fluorescence of 
tetracycline energized by the blue end of the visible spectrum and so cannot be 
photographed on ordinary black and white emulsions; excellent color photomicro-
graphs with Ektachrome, and black and white with fluorescence, can be obtained.''.' 
(See Figs. 1 and 2). 
MEASUREMENT METHODOLOGY 
In order to measure bone turnover in man, we must be able to measure the amount 
of new bone formed in a unit volume of bone in a unit of time. Tetracyclines adminis-
tered in vivo conveniently label bone actively forming, and conveniently they do not 
label unmineralized osteoid or already mineralized bone. The tetracycline labelling 
process supplies the same type of information one would obtain by feeding large 
amounts of alizarin to man, but without the toxicity associated with alizarin. 
In the following material in the Methodology section, the actual measurements 
required are outlined. In the Data Section, the manner in which the measurements 
are manipulated to provide useful information is outlined. We make extensive reference 
to other publications to shorten an already lengthy paper. 
241 
Frost and Villanueva 
'ieure I 
Photomicrograph, Cross Section, femur, basic fuchsin, undecalcified, of the case presented in the 
text. Brightfield, 200X. The black dots are vascular channels. The dark zone connecting the Haversian 
channel at left midcenter to the Haversian channel at 2:00 o'clock is a Volkmann's canal which is 
out of focus. The two Haversian channels are lying in newly formed Haversian systems and are still 
fuchsin permeable in some areas, causing them to appear darker than the remainder of the bone 
visible in this illustration. Parts of 3 Haversian systems banded by achromycin and pronouncedly 
yellow on the original section are in this field but are not demonstrable on the photograph for 
reasons referred to in the text. 
Because of known distributional differences in various parts of single bones, 
complete cross sections were necessary for the following measurements.".".''."." The 
longitudinal grain of bone is associated with much less distributional variation along 
the long axis than is found along the radial and tangential axes. Longitudinal sections 
also provide too limited a sample. We emphasize here, ;ind will reemphasize later, 
that the present measurements are done on the diaphyses of 4 bones of one patient 
and must not be considered representative of norms for the sex and age of all similar 
people. 
The means of measurement used for the data in Charts I and I I are now presented. 
1. Channels/mm'^: The slide was marked with a grid of lines which are scanned 
in increments of one field diameter, using an objective-eyepiece combination of 
known field diameter. The total numbers of longitudinally coursing vascular 
channels and of fields are recorded and reduced to channels/mm^ by calcu-
lation. Relative variation in the present case was small, about 4%. Sampling 
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Figure 2 
Same field and magnification but with Frost's fluorescence set-up. The bright bands are achromycin 
labelled parts of the Haversian systems. The left hand system is doubly banded, the outer band 
being formed during the first, and the inner band during the second achromycin epoch of the case 
discussed in the text. The right hand Haversian system is singly banded and it is not apparent 
from the original material whether the band formed during the first or second epoch. 
technique must be properly designed or systematic distributional effects in-
herent in bone and the observer will introduce error. For example there are 
2 to 3 times as many channels near periosteal surfaces as near endosteal, while 
osteon density and incidence of banded osteons is greater near bone angles 
than in broad bone surfaces. For full details consult references (18, 19). 
2. Percent osteons'^  labelled; labelled osteons per section; percent c^teoid seams; 
percent seams in labelled osteons: Counts are done as in (1) using a fully 
illuminated low power apochromat and color corrected light, tabulating 
counts during the process with the aid of a hand counter. The complete sections, 
rather than a sample, were scanned for labefled osteons per section, using the 
mechanical stage to avoid under—or over lap. (Consult references 12, 18, 19, 
for details of the measurement and for explanation of osteoid seams and 
seam counts). 
3. Osteons banded in outer, middle, inner thirds or doubly banded; banded 
osteon lying in outer, middle or inner thirds of cortices: At any one time 
(a) An osteon is an Haversian system. 
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MEASURED D A T A 
Chart I 
Measured Characteristic Femur Tibia Fibula Metatarsal 
Longitudinal vascular channels/mm^ 13.2 14.1 12.2 16.2 
% Osteons Banded 
(Number counted) 
2.1 
5207 
0.65 
2000 
2.4 
1448 
1.06 
662 
Number banded osteons per section, 
average of 3 or more 149 26 24.5 9 
% banded osteons with osteoid seam 4.7 3.8 24.5 11.1 
Double banded osteons as % 
all banded osteons 11.1 11.5 11.1 
Outer Third of Osteon Banded 26.1 21.7 35.1 28.6 
Middle Third of Osteon Banded 25.8 30.4 25.6 28.6 
Inner Third of Osteon Banded 47.0 47.8 38.4 43.3 
Unclassifiable 11.0 11.7 20.6 22.2 
Banded Osteons Outer Third Cortex 56.3 95.7 84.3 100 
Banded Osteons Middle Third Cortex 26.3 4.2 15.6 0 
Banded Osteons Inner Third Cortex 17.3 0 0 
MEASURED D A T A 
Ch,'irt I i 
Measured Characteristic Femur 
% Osteons Containing Osteoid Seam 
at Amputation (2100 counted) 0.098 
Average Osteon Width 80 u 
Range 18.5 - 135 u 
Average Width Labelled Bands, 19.9 u 
Unselected Range 3.1 - 3 0 u 
Average Width Outer and Middle 
Third Bands 26.0 u 
Average Width Inner Third Bands 6.0 u 
% Section Surface Vascular Channel 10% 
% Section Surface Banded 
.58 
% Empty Lacunae, Banded Osteons 2.1 
% Empty Lacunae, Inner Third Band of 
Doubly Banded Osteons 0.5% 
% Empty Lacunae, Outer Third Band of 
Doubly Banded Osteons 2.3% 
% Empty Lacunae, Mature Haversian Systems 18.5 
% Empty Lacunae, Extra-Haversian 55.7 
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CALCULATED DATA: SEE TEXT 
Chart I I I 
D A T A Femur Tibia Fibula Metatarsal 
Osteons/Banded Osteon 45.4 154 41.4 94.3 
Bande<j Osteons/mm^ 0.290 0.091 0.294 0.176 
Mean Osteon Formation Time 5 wks. 5 wks. 5 wks. 5 wks. 
Osteoid Seam Thickness Formed/Day 2.4 u 
— — — 
Instantaneous % Osteoid Seams 0.75 0.23 0.86 0.38 
Instantaneous Quiescent 
Osteons/Mineralizing Osteon 125 430 115 262 
Biological Half Life, Entire Cortex 
Years 7.6 24.2 7.6 12.6 
Days 2700 8600 2700 4500 
Biological Half Life, Osteons 
Years 2.7 8.6 3,1 5.6 
Days 960 3000 1100 2000 
% Osteons Remodelled per Year 18.7 5.9 21.4 9.4 
% Mass (and os.seous volume less va.scular 
and cell volume) Mineralizing/Day 0.018 0.0058 0.018 0.011 
% Mass in Turnover/Day 0.036 0.012 0.036 0.022 
Ratio of Remodelling Activity per Unit 
Volume (Femur=100) 100 31 101 61 
Ratio of Remodelling Activity in Term.s 
Total Mass in Turnover (Femur=100) 100 19 15 7.5 
% Remodelling Activity in Outer Third Cortex 56.3 95.7 84.3 100 
in a given patient, some osteons will be in the initial stages of formation, 
some in the final stages and some in between. Labelling with tetracycline 
wifl accordingly appear, in the subsequently completed osten, as a band in 
the outer, middle or inner third of the osteon. If two periods of drug dosage 
were close enough together, then some osteons would exhibit double bands, 
one within the other as in Figure 2. Banded osteons were tabulated separately 
by completely scanning sections of femur, tibia, fibula and mentatarsal with 
a low power apochromat. 344 banded osteons were counted for these 
measurements. Doubly banded osteons were counted twice. Of the total 
banded osteons, 11 % could not be classitied as to the third of the osteon 
banded JO these figures do not add up to 100%. 
4. Average width" of osteon; average widths of labelled bands: Banded osteons 
were selected at random and measured with a calibrated eye-piece micro-
meter.'." The totals were reduced to arithmetic means. 49 osteons were 
measured for average osteon width; 29 unselected bands, 29 outer or middle 
third bands and 29 inner third bands for average band widths. The average 
osteon diameter is more than twice the listed value since the vascular canal 
was ignored. The average would be about 240 u with a range of 40-300 u." 
5. Percent empty lacunae: Reference" discusses the technique utilized in these 
measurements. Briefly lacunae without stained contents are empty and dead. 
More empty lacunae exist in extra-Haversian than in Haversian bone''. The 
(a) Width here refers to the distance between cement line and Haversian canal along a radial axis. 
See Figs. I and 2. 
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inference is that increasing age of patient and bone moiety increases the 
counts of empty lacunae. Lacunae opening into the section surfaces are 
not counted. High numerical aperture is essential for the counts. 
6. Percent section surface area: The theory of this technique is that in a well 
mixed, multiphase solid, an infinitely thin plane cut through it will contain 
proportionate surface areas of each phase in direct proportion to the volume 
components of each phase in the solid, provided the area of the plane is 
sufficientiy large to avoid random distributional effects. This ideal plane 
may in turn be sampled by running the cross-hairs of a filar micrometer 
across it, or by other means. Enough runs to reduce random distributional 
effects below the desired level must be made. Consult references 15, 16, 19, 
22, 23, for fuller detafls. 
The Leitz integrating eyepiece micrometer was designed for the above 
type of measurement. The microscope objective is used to provide the 
measured plane, and means for mechanically adding the various phase 
constituents measured are buflt into the instrumenL The femur was selected 
for the measurements because of its greater homogeneity as compared to 
the other bones. For example, the relative variation in counts of total 
labelled osteons per section was only 0.6% in the femur, 4% in the tibia, 
10% in the fibula and 20% in the metatarsal. This suggests that when 
enough cross section area has been sampled the results are valid for adjacent 
parts of a diaphysis, and that more sections of smafl bones must be measured 
to achieve meaningful results." 
In the present integrating eyepiece measurements, 12 fields were measured 
at 150 X and 0.32 N.A. with full illumination of the objective. The estimated 
probable error (a combination of instrument, resolving power, optical, section 
thickness and operator effects)'."."."."." is plus or minus 10% for the vas-
cular and 40% for the banded areas. 
7. The volume of lacunae and canaliculae is 2.5% of the cortex exclusive of 
vascular volume. This measurement is detailed in reference 16. 
8. Charts I and I I list the values obtained for the measurements described above. 
The data in Chart I I I are calculated from the data in Charts I and I I . 
See foflowing text for the reasoning involved. 
DATA ANALYSIS 
1. Osteon turnover: Several informative calculations can be made from the 
data in Charts I and I I . These calculations tefl us how many osteons are 
being formed per unit time and per unit volume of diaphyseal bone. They 
also tefl us the proportion of the total osteon population undergoing re-
modelling per unit time. From this the biological half-life of the osteon 
population may be caculated for each diaphysis measured. 
(b) Haversian bone as defined for the present purpose consists of intact osteons only. In double or 
triple systems only the innermost one is considered Haversian. The remainder of the cortex is 
designated extra-Haversian and includes circumferential lamellae and fragments of old osteons. 
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(A) During the 40 days of drug administration in this case, the percentage 
of the total number of osteons mineralizing was: femur 2 .1%; tibia 
0.65%; fibula 2.4%; metatarsal 1.06%. 
(B) The number of quiescent (fully formed) osteons per mineralizing osteon 
were: femur 45.4; tibia 154; fibula 41.1; metatarsal 94.3. 
(C) From the vascular channels/mm' for each bone the banded osteons/mm', 
thus osteons/mm' mineralizing in 40 days, may be calculated: femur 
0.29; tibia 0.091; tibula 0.29; metatarsal 0.18. Reasoning elaborated 
elsewhere reveals that these figures are representative of mineralizing 
osteons/mm' also. 
(D) Since 40 days is 0.113 years the proportion of osteons undergoing 
minerahzation in a year can be calculated: femur 18.7%; tibia 5.9%; 
fibula 21.4%; metatarsal 9.4%. 
(E) The biological half-life of osteons may now be estimated. Note that 
osteons comprise about 0.3 of the total cortices" and that a different 
half-life for the entire cortex wifl be calculated from direct measurement. 
Osteon half-lives are: femur 2.7; tibia 8.5; tibula 2.4; metatarsal 5.3, 
all in years. 
(F) Several striking features emerge from the above measurements: the 
long half-life of osteons, the similarity of the fibula and femur in 
remodelling activity in this patient, the decrease in remodelling activity 
as examination proceeds from proximal to distal (suggesting that in the 
axial skeleton higher rates occur in this patient) and the remarkable in-
activity of the tibia. One wonders if the tibial values reflect a general 
characteristic or if unrecognized disease affected this bone, but not the 
fibula, in this patient. 
It is reasonably assumed that as much bone is broken down as is formed 
in a given unit time, barring certain pathological states. I f this be true 
then the calculations in (1) should also apply to the rates of bone 
destruction. 
Osteon formation time: Here we will determine how long, on the average, 
it took for an osteon to form in this patient in the bones examined. Two 
separate approaches to the problem are possible in the present case. One 
is based on the frequency distribution of banded osteons, the other on a 
simple proportional measurement of width of the bands and width of the 
osteons. 
(A) About 11% of the total banded osteons were doubly banded, tirst 
in the outer, then in the inner third of the osteon's width. See Figure 2. 
The outer bands average 20 u, the inner bands 6 u thick. A mean time 
interval between labefling epochs of 7 weeks wifl be assumed. This 
is the time during which all of the doubly banded osteons formed. 
If this were the mean time for all osteons there should be about as 
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many that formed faster than 7 weeks as formed slower. The faster 
ones would exhibit one band but the slower ones would exhibit two 
bands, one of which was in the middle third of the osteon. Osteons 
singly banded in either middle or outer thirds constitute about 40% 
of the total but there were only 3 doubly banded osteons one of whose 
bands was in the middle third, in 344 counted. This suggests that the 
mean osteon formation time is less than 7 weeks. A period of about 
5 weeks wfll be assumed because of the following reasoning. 
(B) The average osteon width was 80 u. The average width of the middle 
and outer third achromycin bands in doubly banded osteons was 26 u. 
These bands were labelled during a drug administration time of 11 days. 
80/26 X 11 should be the time of osteon formation. This is 34 days. 
It is not certain that ignoring the first 3 days of drug administration 
is justified or that the rate of osteon formation is steady, however, 
matters which we have assumed to be the case for the moment. Never-
theless the evidence is compatible with an osteon formation time of 
about 5 weeks in this patient. 
(C) Assuming 5 weeks to be correct, 2.4 u of osteoid a day were elaborated 
in mineralizing osteons in this patient. 
3. Instantaneous percentage of osteoid ieamj;'."." This is the percent longitudinal 
vascular channels containing mineralizing bone and thus a seam at any one 
moment. It is assumed here that the percentage of osteoid seams and the 
percentage of labelled osteons are equivalent. Subsequent publications will 
document this assumption. 
(A) Assume osteon formation rate and numbers were equal during the first 
and initial part of the second drug administration periods. Then half 
the singly banded osteons were labelled in the first 11 day period. 
During 11 days some osteons completed, while others commenced, 
formation, causing some overlap. The overlap should be about 11/35 
of the instantaneous value. On this basis the value of osteons forming 
at any one moment for the femur is 0.75''^. The value found at 
amputation was 0.1%. This indicates that the vascular events preceding 
gangrene markedly retarded new osteoid formation. The reader should 
note that the somewhat unrealistic assumptions made here are unfavorable 
to the qualitative result derived. The retardation in bone forming rate 
which occurred during the second achromycin administration epoch 
was probably greater by about 40% than the figure we quote. 
(B) Using a conversion factor of 0.36", the incidence of banded osteons 
can be converted to supply the instantaneous value of osteoid seams. 
Chart I I I lists them. 
4. Turnover of entire diaphysis: Because there are marked variations in the 
proportions of Haversian to extra-Haversian bone in various bones and in 
(a) 11 days drug dosageH-35 days osteon formation time. 
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various ages, determination of osteon turnover or half-life does not tell us 
about turnover or half-life of the entire bone cross-section. Tetracychne 
labelling permits a direct measurement of entire cross-section turnover to be 
made by planimetric means. 
(A) A representative femoral cross-section was measured with the Leitz 
integrating eyepiece micrometer. 10% of the area was vascular channel 
and 0.58% was banded by achromycin. The volume of osteocytes and 
canaliculae is roughly 2%. 
Thus whfle 0.58% of the total cortical volume was banded, 0.63% of 
the dry, fat-free cortical mass was banded, assuming uniform bone 
density, by 40 days of achromycin dosage.'' 
We calculate that 0.018% of this femur was mineralized through new 
bone formation per day. According to previous reasoning this is also 
the amount undergoing destruction per day. If the patient's vascular 
difficulties retarded bone formation during the second achromycin 
dosage period, this figure and those below are too small by a factor of, 
at most, 40%. 
(B) I f the percent of mass undergoing mineralization per day is dependent 
on the percentage of banded osteons, estimates of mineralizing mass 
per day can be calculated for the other bones by simple proportion. 
Values are: tibia 0.0058%; fibula 0.018%; metatarsal 0.011%. 
(C) Bone turnover as utilized here means the sum total of bone being 
formed and degraded. This is twice the formation quantity. The values 
per day: femur 0.036%; tibia 0.012%; fibula 0.036%; metatarsal 
0.022%. These are precent of mass, or percent of osseous volume 
excluding vascular and cellular volume. These measurements assume 
a normal balance between bone formation and destruction, something 
probably not present in the particular case we present. Another, direct 
means of measuring bone resorption quantity and rate is needed to 
evaluate bone turnover in disease states such as osteomalacia and 
senile osteoporosis. 
(D) The remodelling rates and quantities of the various bones may now 
be compared with each other. In terms of mass per unit volume turned 
over, with the femur set arbitrarily at 100, the values are: femur 100; 
tibia 19; fibula 101; metatarsal 61. 
In terms of the absolute mass turning over in the middle thirds of 
the bones, using the banded osteons per complete cross-section as a 
means of proportional comparison, and with the femur set arbitrarily 
at 100, the values are: femur 100; tibia 19; fibula 15; metatarsal 7.5. 
In these calculations we assume there is no significant difference in the 
(b) Bone density is not uniform at the macroscopic or microscopic levels but it is permissible at 
present to assume a uniform average density. For some work on density variations consult 
references 29, 31. 
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size of osteons in the various bones. If high precision is required, this 
assumption would require documentation by measurements on the 
separate bones. 
(E) The mean half-life of the entire cortex may now be calculated, using 
percent of mass mineralizing per day as the base. The values are, 
in years: femur 7.6; tibia 24.2; fibula 7.6; metatarsal 12.6. 
(F) It wfll be noted that the osteon half-life is about 0.3 the above values. 
This suggests that there are different turnover rates for Haversian and 
extra-Haversian bone. 
This inference is substantiated by tinding appreciable portions of cir-
cumferential lamellae in extra-Haversian bone even in very old patients. 
Since circumferential lamellae form during appositional growth in all 
phases of childhood, to be later partially replaced by osteons, it is 
probable that the circumferential lamellae in this patient's extra-Haver-
sian bone is older than the half-life values suggest, in some instances 
probably 40 years old. It may be noted here that micropetrosis affects 
extra-Haversian bone, particularly circumferential lamellae, long before 
it occurs in Haversian bone. Micropetrosis is related to the biological 
age of the bone affected and is not found in young bone." These points 
also suggest a much longer half-life for extra-Haversian than for 
Haversian bone. 
5. Locus of remodelling activity: The distribution of banded osteons in the 
cortical thirds is inhomogeneous. Most of the remodelling activity occurs 
in the outer third of the cortex. In the femur, correction for the difference 
in vascular channels/mm' between periosteal and endosteal surfaces balances 
the difference out, but this correction does not balance out the preference 
for outer third remodelling activity in the rest of the bones. These facts 
pose two questions: why should remodelling activity concentrate near the 
periosteal surfaces, and why are there more vascular channels there than 
elsewhere? While a peculiarity of periosteal blood supply might be postulated, 
it is also possible that the greater surface stresses and strains play a role. 
This is a problem which should prove amenable to experiment using tetracycline 
labelling as an investigative method. 
6. The case we present offers an opportunity to check the thesis that one of 
the factors causing bone cefls to die in vivo"" is age. We performed counts 
of percent empty lacunae in this case which reveal: 
Banded osteons (known to be younger than 95 days) had an average of 2.1% 
empty lacunae. 
The inner band of doubly banded osteons had 0.5%; the outer band 2.3% 
empty lacunae. (Larger differences in empty lacunae between central and 
peripheral lacunae usuafly occur in human Haversian systems so this is a 
poor index of how many cells might die in 95 days). 
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Mature, normally mineralized osteons exhibit an average of 18.5% empty 
lacunae. 
Extra-Haversian bone exhibits an average of 55.7% empty lacunae, but with 
variations. Micropetrotic bone for example comprises about 10% of the 
femur (on which these counts were done) but is 100% dead. It is note-
worthy that no banded micropetrotic areas were seen in any of the 20 sections 
scanned for this purpose or in any of the 42 other cases available to us which 
are labelled in vivo with tetracyclines. 
It appears that the empty-lacuna counting technique might serve as a means 
of assigning relative ages to various parts of the same bone, extraneous factors 
being absent. In this case a definite correlation between age of the bone 
and percent empty lacunae exists. 
DISCUSSION 
A. ) We wish to emphasize that the foregoing measurements and calculations 
are valid only for the diaphyses of the bones of the case examined. Extra-
polations to the whole bone or skeleton or to man as a whole are not justified. 
There is reason to expect that in the future factors of equivalence may be 
determined which will permit such extrapolation.' Such factors would prove 
invaluable in skeletal research and clinical work. 
B. ) The behavior of tetracyclines is not necessarily representative of the behavior 
of all bone-seeking substances. Differences in ionic size, sterism, charge, 
solubility, dielectric constant, chemistry, hydration shells and other factors 
make such similarity unlikely. Nevertheless it is possible in some instances 
that equivalence factors are determinable which would permit the behavior 
of tetracyclines and some other hypothetical substance to be equated. Some 
likely candidates, with the qualifications below in mind, are lead, strontium, 
radium and calcium. 
As an example of how misleading the figures on the amount of bone 
labelled per day by achromycin may be, consider the following: Partly 
published work'. '" reveals that in mineralizing osteons containing an osteoid 
seam there is a thick zone of permeability beyond the seam to diverse ions 
and large molecules. The zone thickness usually exceeds 15 u and represents 
the instantaneous volume of the mineralizing osteon which is readily permeable 
to these substances. Achromycin, however, deposits only in a thin band at 
the periphery of the seam," affecting a volume of bone smaller by a factor 
of about 20. Such a difference in behavior reqiuies explanation and makes one 
cautious about assuming permeability similarities in two different substances. 
C. ) This paper deals with only one aspect of bone turnover as that term is 
commonly understood, and that is bone formation and bone destruction. 
These are not the only mechanisms by which bone-seeking substances may 
enter or leave the skeleton, and therefore not the only important mechanisms 
involved in radiobiological turnover and exchange work with bone. It is 
now possible, however, to assign turnover, in the sense used by us, some 
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quantitative meaning so that other modes of turnover may be placed in 
perspective. 
D. ) The techniques which we have utilized in this work, and the manner in which 
we have applied these techniques, should pave the way for accurate measure-
ment of normal osteoblastic activity in man. This is because the newly 
mineralizing bone labelled by tetracyclines must be formed by osteoblasts, 
and measuring the product is equivalent to measuring the production rate 
directly. 
E. ) With the above means it should be possible to determine what and how 
various factors affect osteoblastic activity. For example, do estrogens really 
accelerate osteoblastic activity in man, or do they exert a different effect? 
How do the corticoids, thyroxin and growth hormone act and what is their 
relative importance? These are some of the questions we hope to be able to 
answer in the future. It is astonishing how little hard, factual knowledge 
exists at present and serves as a basis for a large edifice of clinical theory 
concerning osteoblastic activity.'.' 
F. ) When the factors affecting osteoblastic activity in man have been recognized 
through work on the lines suggested above, the clinician will be able to cure 
osteoporosis of any type, to affect bone growth in any desired manner and to 
cause fractures to heal more dependably and in less time than is currently 
required. Much work, of course, lies between us and such capabilities. 
G. ) The bone formation studied in the present case was lamellar bone formation. 
It has been pointed out elsewhere that fibrous and lameflar bone osteoblastic 
activity differ in some manner in their chemical processes and in their regu-
latory mechanisms.'" In past experimental work on osteoblastic activity, 
failure to distinguish between these two fundamental bone types necessarily 
invalidates the interpretation of such research.' ' 
SUMMARY 
In vivo tetracycline labelling of bones from one patient, from which undecalcified 
sections of the femur, tibia, fibula and metatarsal were made, permitted the direct 
measurement or estimation in a 57 year old man of the following aspects of bone 
physiology: 
Osteon turnover rate and half-life in the various bones examined. 
Total diaphyseal bone turnover rate and half-life in the various bones examined. 
Mean time of osteon formation. 
Locus of the major part of bone remodelling activity. 
Comparison of turnover rates in different bones. 
Quantitation of bone formation and destruction per unit time and volume in the 
bones examined. 
The techniques used in making the above determinations offer new means of 
studying human bone physiology. Within their limitations of scope, they should prove 
252 
Measurement of Bone Formation 
useful in advancing our knowledge of skeletal dynamics. 
The data presented in this paper are the first time such direct measurements have 
been made in man. 
APPENDEX (A) 
CASE PRESENTATION 
Briefly, a 57 year old Caucasian male developed an aortic aneurysm which was 
resected and replaced with a prosthesis. An interval of good health followed. Then 
infection and leakage, after several temporizing surgical procedures, led to complete 
ligation of the blood supply to the left lower extremity, gangrene and pertrochanteric 
amputation. These events occurred during two separate hospitalizations in each of 
which the patient received known amounts of achromycin for known time periods. 
There were no objective or subjective circulatory difficulties in his lower extremities 
until a thrombophlebitis of 5 days duration appeared on the 48th day after first achro-
mycin administration. Transient circulatory difficulty appeared on the 75th day after 
a surgical procedure. Gangrene occurred on the 97th day after ligation of all collaterals 
to the limb and extirpation of the entire left limb of the arterial prosthesis. Amputation 
was done on the 102nd day. The amputated hmb provided the material for the 
present study. 
Achromycin was administered in dosage of 2.0 gm/day on the following days, 
numbering them from the day of first administration 1-3; 11-21; 63-88. No achromycin 
was given on the other days. These periods will be referred to subsequently as the 
first and second achromycin epochs, days 1-3 being ignored. 
Multiple other antibiotics were administered but no other tetracyclines. (All of 
the other antibiotics and the tetracyclines have been tested in vitro for bone staining: 
only the tetracyclines fluoresce and stain undecalcified bone visibly.) 
REFERENCES 
1. Albright, F., Bloomberg, E., and Smith, P. H.: Post-menopausal osteoporosis, Tr. A. Am. 
Physicians 55:298, 1940. 
2. Albright, F.: Osteoporosis, Ann. Int. Med. 27:861, 1947. 
3. Allen, R. M. : The Microscope, New York, D. Van Nostrand, 1940. 
4. Allen, R. M.: Photomicrography, New York, D. Van Nostrand, 1941. 
5. Eckelmann, W. R., Kulp, J. L., and Schulert, A. R.: Strontium-In man, I I . Science 
127:266,1958. 
6. Eastman Kodak Co.: Photomicrography, ed. 13, Rochester, New York, 1935. 
7. Frost, H. M. : Preparation of thin undecalcified bone sections by rapid manual method, 
Stain Technol. 33:272, 1958. 
8. Frost, H. M. : Staining of fresh, undecalcified, thin bone sections. Stain Technol. 34:135, 1959. 
9. Frost, H. M. : Some observations on bone mineral in a case of vitamin D resistant rickets, 
Henry Ford Hosp. M. Bull. 6:300, 1958. 
10. Frost, H. M.: In vivo osteocyte death, J. Bone & Joint Surg. 42A:138, 1960. 
253 
Frost and Villanueva 
11. Frost, H. M. : Micropetrosis, J. Bone & Joint Surg. 42A:144, 1960. 
12. Frost, H. M. : In vivo bone staining with tetracyclines. Stain Technol. 35:135, 1960. 
13. Frost, H. M . : An economical microfluorescence set-up for detection of tetracyclines in 
bone, Henry Ford Hosp. M. Bull. 8:197, 1960. 
14. Frost, H. M. : Observations on fibrous and lamellar bone, Henry Ford Hosp. M. Bull. 8:199, 
1960. 
15. Frost, H. M. : New bone affection: Feathering, J. Bone & Joint Surg. 42A:447, 1960. 
16. Frost, H. M. : Measurement of osteocytes per unit volume and volume components of 
osteocytes and canaliculae in man, Henry Ford Hosp. M. Bull. 8:208, 1960. 
17. Frost, H. M. : Unpublished work. 
18. Frost, H. M., and Villanueva, A. R.: Observations on osteoid seams, Henry Ford Hosp. 
M. Bull 8:212, 1960. 
19. Frost, H. M., and Villanueva, A. R.: Measurement of osteoblastic activity in diaphyseal 
bone. Stain Technol. (In press)., 
20. Frost, H. M., Villanueva, A. R., and Roth, H.: Pyogenic osteomyelitis: Diffusion in live 
and dead bone with particular reference to the tetracycline antibiotics, Henry Ford Hosp. M. Bull. 
8:255, 1960. 
21. Hardy, A. C, and Perrin, F. H.: Principles of Optics, New York, McGraw-Hill, 1932. 
22. Hennig, A.: Measuring and counting in microscopy, Zeiss Werkzeitschrift No. 30, Dec. 1958. 
23. Hennig, A.: Das Problem der Kernmessung. Eine Zusammenfassung und Erweiterung der 
Mikroskopischen Messtechnik, Mikroskopie 12:174, 1957, 
24. Jaffe, H. L., and Pomeranz, M. M.: Changes in bones of extremities amputated because 
of arteriovascular disease. Arch. Surg. 29:566, 1934. 
25. Jenkins, F. A., and White, H. E.: Fundamentals of Optics, ed. 2, New York, McGraw-Hill 
1950. 
26. Milch, R. A., Rail, D. P., and Tobie, J. E.: Bone localization of the tetracyclines, J. Nat 
Cancer Inst. 19:87, 1957. 
27. Milch, R. A., Rail, D. P., and Tobie, J. E.: Fluorescence of tetracycline antibiotics in 
bone, J. Bone & Joint Surg. 40A:897, 1958. 
28. Needham, G. H.: Practical Use of the Microscope, Including Photomicrography, Springfield, 
Thomas, 1958. 
29. Robinson, R. A., and Elliott, S. R.: Water content of bone. I . Mass of water, inorganic 
crystals, organic matrix, and "CO2 Space" components in a unit volume of dog bone, J. Bone & 
Joint Surg. 39A:167, 1957. 
30. Sherman, M. S., and Selakovich, W. G.: Bone changes in chronic circulatory insufficiency; 
histopathological study, J. Bone & Joint Surg. 39A:892, 1957. 
31. Trotter, M., and Peterson, R. R.: Ash weight of human skeletons in per cent of their 
dry, fat-free weight, Anat. Rec. 123:341, 1955. 
254 
